Natera, Inc. (NTRA)
395.88
-4.77
(-1.19%)
USD |
NASDAQ |
Oct 07, 15:56
Natera Net Income (Quarterly) : -66.97M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -66.97M |
| March 31, 2026 | -85.09M |
| December 31, 2025 | 47.26M |
| September 30, 2025 | -87.54M |
| June 30, 2025 | -100.94M |
| March 31, 2025 | -66.94M |
| December 31, 2024 | -53.77M |
| September 30, 2024 | -31.59M |
| June 30, 2024 | -37.46M |
| March 31, 2024 | -67.60M |
| December 31, 2023 | -78.03M |
| September 30, 2023 | -109.03M |
| June 30, 2023 | -110.80M |
| March 31, 2023 | -136.94M |
| December 31, 2022 | -142.57M |
| September 30, 2022 | -121.48M |
| June 30, 2022 | -145.15M |
| March 31, 2022 | -138.60M |
| December 31, 2021 | -140.56M |
| September 30, 2021 | -151.27M |
| June 30, 2021 | -116.03M |
| March 31, 2021 | -63.85M |
| December 31, 2020 | -76.41M |
| September 30, 2020 | -58.32M |
| June 30, 2020 | -59.64M |
| Date | Value |
|---|---|
| March 31, 2020 | -35.37M |
| December 31, 2019 | -35.18M |
| September 30, 2019 | -23.14M |
| June 30, 2019 | -32.42M |
| March 31, 2019 | -34.09M |
| December 31, 2018 | -31.84M |
| September 30, 2018 | -29.62M |
| June 30, 2018 | -33.82M |
| March 31, 2018 | -32.87M |
| December 31, 2017 | -47.22M |
| September 30, 2017 | -27.86M |
| June 30, 2017 | -29.07M |
| March 31, 2017 | -33.48M |
| December 31, 2016 | -37.91M |
| September 30, 2016 | -26.02M |
| June 30, 2016 | -23.16M |
| March 31, 2016 | -8.685M |
| December 31, 2015 | -22.96M |
| September 30, 2015 | -17.63M |
| June 30, 2015 | -19.68M |
| March 31, 2015 | -10.00M |
| September 30, 2014 | 3.724M |
| June 30, 2014 | -0.514M |
| March 31, 2014 | -9.616M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Guardant Health, Inc. | -120.14M |
| Myriad Genetics, Inc. | -43.20M |
| CareDx, Inc. | 110.64M |
| Caris Life Sciences, Inc. | -0.637M |
| BioRestorative Therapies, Inc. | -2.154M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 752.75M |
| Total Expenses (Quarterly) | 819.72M |
| EPS Diluted (Quarterly) | -0.4674 |
| Enterprise Value | 56.69B |
| Gross Profit Margin (Quarterly) | 63.70% |
| Profit Margin (Quarterly) | -8.90% |
| Earnings Yield | -0.35% |
| Normalized Earnings Yield | -0.3408 |